CoChat

Female Sexual Dysfunction—Medical and Psychological Treatments, Committee 14

Kingsberg, Sheryl A., Althof, Stanley, Simon, James A., Bradford, Andrea, Bitzer, Johannes, Carvalho, Joana, Flynn, Kathryn E., Nappi, Rossella E., Reese, Jennifer B., Rezaee, Roya L., Schover, Leslie, Shifrin, Jan L. · 2017 · The Journal of Sexual Medicine
Cited by 125

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

Introduction: Since the millennium we have witnessed significant strides in the science and treatment of female sexual dysfunction (FSD). This forward progress has included (i) the development of new theoretical models to describe healthy and dysfunctional sexual responses in women; (ii) alternative classification strategies of female sexual disorders; (iii) major advances in brain, hormonal, psychological, and interpersonal research focusing on etiologic factors and treatment approaches; (iv) strong and effective public advocacy for FSD; and (v) greater educational awareness of the impact of FSD on the woman and her partner. Aims: To review the literature and describe the best practices for assessing and treating women with hypoactive sexual desire disorder, female sexual arousal disorder, and female orgasmic disorders. Methods: The committee undertook a comprehensive review of the literature and discussion among themselves to determine the best assessment and treatment methods. Results: Using a biopsychosocial lens, the committee presents recommendations (with levels of evidence) for assessment and treatment of hypoactive sexual desire disorder, female sexual arousal disorder, and female orgasmic disorders. Conclusion: The numerous significant strides in FSD that have occurred since the previous International Consultation of Sexual Medicine publications are reviewed in this article. Although evidence supports an integrated biopsychosocial approach to assessment and treatment of these disorders, the biological and psychological factors are artificially separated for review purposes. We recognize that best outcomes are achieved when all relevant factors are identified and addressed by the clinician and patient working together in concert (the sum is greater than the whole of its parts).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jsxm.2017.05.018

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 262

  1. Basson, 2001, Human sex-response cycles, J Sex Marital Ther, 27, 33, 10.1080/00926230152035831 · DOI · Paper page
  2. Parish, 2016, Toward a more evidence-based nosology and nomenclature for female sexual dysfunction—part II, J Sex Med, 13, 1888
  3. Portman, 2014, Vulvovaginal atrophy terminology consensus conference panel genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society, Menopause, 21, 1063, 10.1097/GME.0000000000000329 · DOI · Paper page
  4. Arnow, 2009, Women with hypoactive sexual desire disorder compared to normal females: a functional magnetic resonance imaging study, Neuroscience, 158, 484, 10.1016/j.neuroscience.2008.09.044 · DOI · Paper page
  5. Joffe, 2016, FDA approval of flibanserin—treating hypoactive sexual desire disorder, N Engl J Med, 374, 101, 10.1056/NEJMp1513686 · DOI
  6. Kaschak, 2014, A new view of women's sexual problems, 10.4324/9781315808970 · DOI · Paper page
  7. Althof, 2005, Psychological and interpersonal dimensions of sexual function or dysfunction, J Sex Med, 26, 793
  8. Gomez-Robles, 2015, Relaxed genetic control of cortical organization in human brains compared with chimpanzees, Proc Natl Acad Sci U S A, 112, 14799, 10.1073/pnas.1512646112 · DOI · Paper page
  9. Huynh, 2012, High-intensity erotic visual stimuli de-activate the primary visual cortex in women, J Sex Med, 9, 1579
  10. American Psychiatric Association, 1995, Training in and dissemination of empirically-validated psychological treatments: report and recommendations, Clin Psychol, 48, 3
  11. Brotto, 2010, Women's sexual desire and arousal disorders, J Sex Med, 7, 586
  12. Rosen, 2006, Normal sexual response in women, Obstet Gynecol Clin North Am, 33, 515, 10.1016/j.ogc.2006.09.005 · DOI
  13. Basson, 2001, Female sexual response: the role of drugs in the management of sexual dysfunction, Obstet Gynecol, 98, 350
  14. Basson, 2005, Assessment and management of women's sexual dysfunctions: problematic desire and arousal, J Sex Med, 2, 291
  15. Parish, 2016, Hypoactive sexual desire disorder: a review of epidemiology, biopsychology, diagnosis, and treatment, Sex Med Rev, 4, 103, 10.1016/j.sxmr.2015.11.009 · DOI · Paper page
  16. Berger, 2016, Association between infertility and sexual dysfunction in men and women, Sex Med Rev, 4, 353, 10.1016/j.sxmr.2016.05.002 · DOI
  17. McCall, 2007, Differences between pre- and postmenopausal women in cues for sexual desire, J Sex Med, 4, 364
  18. Hill, 2011, Assessing gynecologic and breast cancer survivors' sexual health care needs, Cancer, 117, 2643, 10.1002/cncr.25832 · DOI · Paper page
  19. Flynn, 2012, Patient experiences with communication about sex during and after treatment for cancer, Psychooncology, 21, 594, 10.1002/pon.1947 · DOI · Paper page
  20. Quirk, 2002, Development of a sexual function questionnaire for clinical trials of female sexual dysfunction, J Womens Health Gender Based Med, 11, 277, 10.1089/152460902753668475 · DOI · Paper page
  21. Flynn, 2013, Development of the NIH PROMIS® sexual function and satisfaction measures in patients with cancer, J Sex Med, 10, 43
  22. Flynn, 2015, Development and validation of a single-item screener for self-reporting sexual problems in U.S. adults, J Gen Intern Med, 30, 1468, 10.1007/s11606-015-3333-3 · DOI
  23. Dennerstein, 2006, Sexual desire disorders in women, 315, 10.1002/9780470755235.ch21 · DOI
  24. Kingsberg, 2013, Hypoactive sexual desire in women, Menopause, 20, 1284, 10.1097/GME.0000000000000131 · DOI
  25. Annon, 1976, The PLISSIT model, J Sex Educ Ther, 2, 1, 10.1080/01614576.1976.11074483 · DOI · Paper page
  26. Pyke, 2015, Psychological treatment trials for hypoactive sexual desire disorder: a sexual medicine critique and perspective, J Sex Med, 12, 2451
  27. Pyke, 2015, Models vs. realities in female sexual dysfunction, J Sex Med, 12, 1977
  28. McCabe, 2015, Editorial comment on “Psychological treatment trials for hypoactive sexual desire disorder: a sexual medicine critique and perspective.”, J Sex Med, 12, 2459
  29. Hurlbert, 1993, A comparative study using orgasm consistency training in the treatment of women reporting hypoactive sexual desire, J Sex Marital Ther, 19, 41, 10.1080/00926239308404887 · DOI · Paper page
  30. Hurlbert, 1993, Orgasm consistency training in the treatment of women reporting hypoactive sexual desire: an outcome comparison of women-only groups and couples-only groups, J Behav Ther Exp Psychiatry, 24, 3, 10.1016/0005-7916(93)90003-F · DOI
  31. MacPhee, 1995, Low sexual desire in women: the effects of marital therapy, J Sex Marital Ther, 21, 159, 10.1080/00926239508404396 · DOI · Paper page
  32. Stephenson, 2013, Relationship satisfaction as a predictor of treatment response during cognitive behavioral sex therapy, Arch Sex Behav, 42, 143, 10.1007/s10508-012-9961-3 · DOI
  33. Seal, 2009, The association between body esteem and sexual desire among college women, Arch Sex Behav, 38, 866, 10.1007/s10508-008-9467-1 · DOI
  34. Althof, 2011, Sex therapy and combined (sex and medical) therapy, J Sex Med, 8, 1827
  35. Brotto, 2012, A brief mindfulness-based cognitive behavioral intervention improves sexual functioning versus wait-list control in women treated for gynecologic cancer, Gynecol Oncol, 125, 320, 10.1016/j.ygyno.2012.01.035 · DOI · Paper page
  36. Heiman, 1988, Becoming orgasmic: a sexual and personal growth program for women (revised and expanded edition)
  37. Nobre, 2008, Cognitions, emotions, and sexual response: analysis of the relationship among automatic thoughts, emotional responses, and sexual arousal, Arch Sex Behav, 37, 652, 10.1007/s10508-007-9258-0 · DOI
  38. Sills, 2005, The Sexual Interest and Desire Inventory-Female (SIDI-F): item response analyses of data from women diagnosed with hypoactive sexual desire disorder, J Sex Med, 2, 801
  39. Mintz, 2012, Bibliotherapy for low sexual desire: evidence for effectiveness, J Couns Psychol, 59, 471
  40. Balzer, 2015, Comparing two books and establishing probably efficacious treatment for low sexual desire, J Couns Psychol, 62, 321
  41. Palaniappan, Skills vs. pills: comparative effectiveness for low sexual desire in women, 10.1080/0092623X.2017.1305029 · DOI
  42. Nappi, 2009, The use of estrogen therapy in women's sexual functioning (CME), J Sex Med, 6, 603
  43. Wierman, 2010, Endocrine aspects of women's sexual function, J Sex Med, 7, 561
  44. Burnett, 2010, Future sexual medicine physiological treatment targets, J Sex Med, 7, 3269
  45. Giraldi, 2004, Physiology of female sexual function: animal models, J Sex Med, 1, 237
  46. Munarriz, 2002, Biology of female sexual function, Urol Clin North Am, 29, 685, 10.1016/S0094-0143(02)00069-1 · DOI
  47. Basson, 2010, Testosterone therapy for reduced libido in women, Ther Adv Endocrinol Metab, 1, 155, 10.1177/2042018810379588 · DOI
  48. Nappi, 2013, Pharmacogenomics and sexuality: a vision, Climacteric, 16, 25, 10.3109/13697137.2013.806402 · DOI
  49. Nappi, 2012, The use of hormone therapy for the maintenance of urogynecological and sexual health post WHI, Climacteric, 15, 267, 10.3109/13697137.2012.657589 · DOI
  50. Nappi, 2007, New attitudes to sexuality in the menopause: clinical evaluation and diagnosis, Climacteric, 10, 105, 10.1080/13697130701599876 · DOI
  51. Levine, 2008, Vulvovaginal atrophy is strongly associated with female sexual dysfunction among sexually active postmenopausal women, Menopause, 15, 661, 10.1097/gme.0b013e31815a5168 · DOI · Paper page
  52. Nappi, 2009, LEI (Lack of tEstosterone Impact) survey in a clinical sample with surgical menopause, Climacteric, 12, 533, 10.3109/13697130902972005 · DOI
  53. Davis, 2016, Androgens and female sexual function and dysfunction—findings from the Fourth International Consultation of Sexual Medicine, J Sex Med, 13, 168
  54. Santoro, 2016, Role of estrogens and estrogen-like compounds in female sexual function and dysfunction, J Sex Med, 13, 305
  55. Worsley, 2016, Hormones and female sexual dysfunction: beyond estrogens and androgens—findings from the Fourth International Consultation on Sexual Medicine, J Sex Med, 13, 283
  56. Agmo, 2014, Animal models of female sexual dysfunction: basic considerations on drugs, arousal, motivation and behavior, Pharmacol Biochem Behav, 121, 3, 10.1016/j.pbb.2013.10.003 · DOI
  57. Levin, 2014, The pharmacology of the human female orgasm—its biological and physiological backgrounds, Pharmacol Biochem Behav, 121, 62, 10.1016/j.pbb.2014.02.010 · DOI
  58. Maravilla, 2008, Magnetic resonance imaging and the female sexual response: overview of techniques, results, and future directions, J Sex Med, 5, 1559
  59. Clayton, 2010, Flibanserin: a potential treatment for hypoactive sexual desire disorder in premenopausal women, Womens Health, 6, 639
  60. Simon, 2014, Efficacy and safety of flibanserin in postmenopausal women with hypoactive sexual desire disorder: results of the SNOWDROP trial, Menopause, 21, 633, 10.1097/GME.0000000000000134 · DOI
  61. Reviriego, 2014, Flibanserin for female sexual dysfunction, Drugs Today, 50, 549, 10.1358/dot.2014.50.8.2198036 · doi:10.1358/dot.2014.50.8.2198036
  62. Derogatis, 2012, Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study, J Sex Med, 9, 1074
  63. Jayne, 2012, Open-label extension study of flibanserin in women with hypoactive sexual desire disorder, J Sex Med, 9, 3180
  64. Thorp, 2012, Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the DAISY study, J Sex Med, 9, 793
  65. Katz, 2013, Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial, J Sex Med, 10, 1807
  66. Goldfischer, 2008, Efficacy of continued flibanserin treatment on sexual desire and satisfying sexual events in premenopausal women with hypoactive sexual desire disorder: results from the ROSE study, J Sex Med, 5, 174
  67. Nappi, 2009, Efficacy of flibanserin as a potential treatment for hypoactive sexual desire disorder in European premenopausal women: results from the ORCHID trial, J Sex Med, 6, 409
  68. Thorp, 2014, Improving prospects for treating hypoactive sexual desire disorder (HSDD): development status of flibanserin, BJOG, 121, 1328, 10.1111/1471-0528.12878 · DOI
  69. Segraves, 2004, Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women, J Clin Psychopharmacol, 24, 339, 10.1097/01.jcp.0000125686.20338.c1 · DOI · Paper page
  70. Clayton, 2014, Sexual dysfunction associated with major depressive disorder and antidepressant treatment, Expert Opin Drug Saf, 13, 1361, 10.1517/14740338.2014.951324 · DOI · Paper page
  71. Belkin, 2015, Drugs in early clinical development for the treatment of female sexual dysfunction, Expert Opin Investig Drugs, 24, 159, 10.1517/13543784.2015.978283 · DOI
  72. Caruso, 2004, Placebo-controlled study on efficacy and safety of daily apomorphine SL intake in premenopausal women affected by hypoactive sexual desire disorder and sexual arousal disorder, Urology, 63, 955, 10.1016/j.urology.2003.12.018 · DOI
  73. Pfaus, 2007, Bremelanotide: an overview of preclinical CNS effects on female sexual function, J Sex Med, 4, 269
  74. Uckert, 2014, Melanocortin receptor agonists in the treatment of male and female sexual dysfunctions: results from basic research and clinical studies, Expert Opin Investig Drugs, 23, 1477, 10.1517/13543784.2014.934805 · DOI
  75. DeRogatis, 2014, Bremelanotide for female sexual dysfunctions: responder analyses from a phase 2B dose-ranging study, Obstet Gynecol, 123, 26s, 10.1097/01.AOG.0000447289.23270.72 · DOI
  76. Portman, 2014, Bremelanotide for hypoactive sexual desire disorder: analyses from a phase 2B dose-ranging study, Obstet Gynecol, 123, 31s, 10.1097/01.AOG.0000447299.24824.6b · doi:10.1097/01.aog.0000447299.24824.6b
  77. Clayton, 2016, Bremelanotide for female sexual dysfunction in premenopausal women: a randomized placebo-controlled dose-finding trial, Womens Health, 12, 325
  78. Poels, 2013, Toward personalized sexual medicine (part 2): testosterone combined with a PDE5 inhibitor increases sexual satisfaction in women with HSDD and FSAD, and a low sensitive system for sexual cues, J Sex Med, 10, 810
  79. van Rooij, 2013, Toward personalized sexual medicine (part 3): testosterone combined with a serotonin1A receptor agonist increases sexual satisfaction in women with HSDD and FSAD, and dysfunctional activation of sexual inhibitory mechanisms, J Sex Med, 10, 824
  80. Poels, 2014, Two novel combined drug treatments for women with hypoactive sexual desire disorder, Pharmacol Biochem Behav, 121, 71, 10.1016/j.pbb.2014.02.002 · DOI
  81. van Rooij, 2015, Efficacy of testosterone combined with a PDE5 inhibitor and testosterone combined with a serotonin (1A) receptor agonist in women with SSRI-induced sexual dysfunction. A preliminary study, Eur J Pharmacol, 753, 246, 10.1016/j.ejphar.2014.10.061 · DOI
  82. van der Made, 2009, The influence of testosterone combined with a PDE5-inhibitor on cognitive, affective, and physiological sexual functioning in women suffering from sexual dysfunction, J Sex Med, 6, 777
  83. Dawson, 2013, Habituation of sexual responses in men and women: a test of the preparation hypothesis of women's genital responses, J Sex Med, 10, 990
  84. Gannon, 1986, Cognitive-physiological discordance as an etiologic factor in psychophysiological disorders, Adv Behav Res Ther, 8, 223, 10.1016/0146-6402(86)90006-8 · DOI
  85. Prause, 2013, Instructions to rate genital vasocongestion increases genital and self-reported sexual arousal but not coherence between genital and self-reported sexual arousal, J Sex Med, 10, 2219
  86. Suschinsky, 2012, Is sexual concordance related to awareness of physiological states?, Arch Sex Behav, 41, 199, 10.1007/s10508-012-9931-9 · DOI
  87. Suschinsky, 2014, The relationship between sexual concordance and interoception in anxious and nonanxious women, J Sex Med, 11, 942
  88. Rieger, 2015, Sexual arousal: the correspondence of eyes and genitals, Biol Psychol, 104, 56, 10.1016/j.biopsycho.2014.11.009 · DOI
  89. Carvalho, 2013, Gender differences in sexual arousal and affective responses to erotica: the effects of type of film and fantasy instructions, Arch Sex Behav, 42, 1011, 10.1007/s10508-013-0076-2 · DOI
  90. Heiman, 1977, A psychophysiological exploration of sexual arousal patterns in females and males, Psychophysiology, 14, 266, 10.1111/j.1469-8986.1977.tb01173.x · DOI · Paper page
  91. Laan, 1994, Women's sexual and emotional responses to male- and female-produced erotica, Arch Sex Behav, 23, 153, 10.1007/BF01542096 · DOI · Paper page
  92. Rellini, 2005, The relationship between women's subjective and physiological sexual arousal, Psychophysiology, 42, 116, 10.1111/j.1469-8986.2005.00259.x · DOI · Paper page
  93. Kukkonen, 2007, Thermography as a physiological measure of sexual arousal in both men and women, J Sex Med, 4, 93
  94. Kukkonen, 2010, An evaluation of the validity of thermography as a physiological measure of sexual arousal in a non-university adult sample, Arch Sex Behav, 39, 861, 10.1007/s10508-009-9496-4 · DOI
  95. Waxman, 2009, Laser Doppler imaging of genital blood flow: a direct measure of female sexual arousal, J Sex Med, 6, 2278
  96. Prause, 2014, Frontal alpha asymmetry and sexually motivated states, Psychophysiology, 51, 226, 10.1111/psyp.12173 · DOI
  97. Laan, 2008, Genital responsiveness in healthy women with and without sexual arousal disorder, J Sex Med, 5, 1424
  98. Meston, 2010, The sensitivity of continuous laboratory measures of physiological and subjective sexual arousal for diagnosing women with sexual arousal disorder, J Sex Med, 7, 938
  99. Rellini, 2006, The sensitivity of event logs, self-administered questionnaires and photoplethysmography to detect treatment-induced changes in female sexual arousal disorder (FSAD) diagnosis, J Sex Med, 3, 283
  100. Sungur, 2014, A comparison of DSM-IV-TR and DSM-5 definitions for sexual dysfunctions: critiques and challenges, J Sex Med, 11, 364
  101. Sarin, 2013, Disentangling desire and arousal: a classificatory conundrum, Arch Sex Behav, 42, 1079, 10.1007/s10508-013-0100-6 · DOI
  102. Mitchell, 2014, How do men and women define sexual desire and sexual arousal?, J Sex Marital Ther, 40, 17, 10.1080/0092623X.2012.697536 · DOI
  103. Balon, 2014, Female sexual interest/arousal disorder: a diagnosis out of thin air, Arch Sex Behav, 43, 1227, 10.1007/s10508-013-0247-1 · DOI
  104. Giraldi, 2013, Female sexual arousal disorders, J Sex Med, 10, 58
  105. Graham, 2014, Response to Balon and Clayton (2014): female sexual interest/arousal disorder is a diagnosis more on firm ground than thin air, Arch Sex Behav, 43, 1231, 10.1007/s10508-013-0248-0 · DOI
  106. Woo, 2011, The role of sex guilt in the relationship between culture and women's sexual desire, Arch Sex Behav, 40, 385, 10.1007/s10508-010-9609-0 · DOI
  107. Woo, 2012, Sex guilt mediates the relationship between religiosity and sexual desire in East Asian and Euro-Canadian college-aged women, Arch Sex Behav, 41, 1485, 10.1007/s10508-012-9918-6 · DOI
  108. Abdolsalehi-Najafi, 2013, Sex guilt and life satisfaction in Iranian-American women, Arch Sex Behav, 42, 1063, 10.1007/s10508-013-0084-2 · DOI
  109. White, 2013, Factors influencing older black women's sexual functioning and their disclosure of sexual concerns, OA Womens Health, 1
  110. Davison, 2009, The relationship between self-reported sexual satisfaction and general well-being in women, J Sex Med, 6, 2690
  111. Jiann, 2009, Risk factors for individual domains of female sexual function, J Sex Med, 6, 3364
  112. Pascoal, 2013, Emotional intimacy is the best predictor of sexual satisfaction of men and women with sexual arousal problems, Int J Impot Res, 25, 51, 10.1038/ijir.2012.38 · DOI
  113. Burri, 2013, A discordant monozygotic twin approach to testing environmental influences on sexual dysfunction in women, Arch Sex Behav, 42, 961, 10.1007/s10508-013-0089-x · DOI
  114. Both, 2011, Focusing “hot” or focusing “cool”: attentional mechanisms in sexual arousal in men and women, J Sex Med, 8, 167
  115. Nelson, 2011, Non-erotic thoughts, attentional focus, and sexual problems in a community sample, Arch Sex Behav, 40, 395, 10.1007/s10508-010-9693-1 · DOI
  116. Lacefield, 2012, Non-erotic cognitive distractions during sexual activity in sexual minority and heterosexual young adults, Arch Sex Behav, 41, 391, 10.1007/s10508-011-9792-7 · DOI
  117. Satinsky, 2012, An assessment of body appreciation and its relationship to sexual function in women, Body Image, 9, 137, 10.1016/j.bodyim.2011.09.007 · DOI · Paper page
  118. Shaughnessy, 2014, Self-appraisals of arousal-oriented online sexual activities in university and community samples, Arch Sex Behav, 43, 1187, 10.1007/s10508-013-0115-z · DOI
  119. Vilarinho, 2014, Affective and cognitive determinants of women's sexual response to erotica, J Sex Med, 11, 2671
  120. Satinsky, 2015, Female sexual subjectivity and verbal consent to receiving oral sex, J Sex Marital Ther, 41, 413, 10.1080/0092623X.2014.918065 · DOI
  121. Ter Kuile, 2007, Preliminary evidence that acute and chronic daily psychological stress affect sexual arousal in sexually functional women, Behav Res Ther, 45, 2078, 10.1016/j.brat.2007.03.006 · DOI
  122. Hamilton, 2013, Chronic stress and sexual function in women, J Sex Med, 10, 2443
  123. Zollman, 2013, The mediating effect of daily stress on the sexual arousal function of women with a history of childhood sexual abuse, J Sex Marital Ther, 39, 176, 10.1080/0092623X.2012.691950 · DOI
  124. McCarthy, 2011, The impact of sexual trauma on sexual desire and function, Adv Psychosom Med, 31, 105, 10.1159/000328919 · doi:10.1159/000328919
  125. Ciocca, 2015, Attachment styles and sexual dysfunctions: a case-control study of female and male sexuality, Int J Impot Res, 27, 81, 10.1038/ijir.2014.33 · DOI
  126. Burri, 2014, Correlates of female sexual functioning: adult attachment and differentiation of self, J Sex Med, 11, 2188
  127. Stephenson, 2010, Differentiating components of sexual well-being in women: are sexual satisfaction and sexual distress independent constructs?, J Sex Med, 7, 2458
  128. Kalmbach, 2012, Specificity of anhedonic depression and anxious arousal with sexual problems among sexually healthy young adults, J Sex Med, 9, 505
  129. Burri, 2012, The etiological relationship between anxiety sensitivity, sexual distress, and female sexual dysfunction is partly genetically moderated, J Sex Med, 9, 1887
  130. Dennerstein, 2008, Sexual function, dysfunction, and sexual distress in a prospective, population-based sample of mid-aged, Australian-born women, J Sex Med, 5, 2291
  131. Lonnee-Hoffmann, 2014, Sexual function in the late postmenopause: a decade of follow-up in a population-based cohort of Australian women, J Sex Med, 11, 2029
  132. Valadares, 2014, Sexual activity in Brazilian women aged 50 years or older within the framework of a population-based study, Menopause, 21, 295, 10.1097/GME.0b013e3182987231 · DOI
  133. Galinsky, 2012, Sexual touching and difficulties with sexual arousal and orgasm among U.S. older adults, Arch Sex Behav, 41, 875, 10.1007/s10508-011-9873-7 · DOI
  134. Christensen, 2013, Reducing shame in a game that predicts HIV risk reduction for young adult MSM: a randomized trial delivered nationally over the Web, J Int AIDS Soc, 16, 18716, 10.7448/IAS.16.3.18716 · DOI
  135. Fichten, 1983, Methodological issues in the study of sex therapy—effective components in the treatment of secondary orgasmic dysfunction, J Sex Marital Ther, 9, 191, 10.1080/00926238308405847 · DOI
  136. Eugenio, 2012, Comprehensive self-management reduces the negative impact of irritable bowel syndrome symptoms on sexual functioning, Digest Dis Sci, 57, 1636, 10.1007/s10620-012-2047-1 · DOI
  137. Kim, 2013, Effects of yoga on sexual function in women with metabolic syndrome: a randomized controlled trial, J Sex Med, 10, 2741
  138. Wing, 2013, Effect of intensive lifestyle intervention on sexual dysfunction in women with type 2 diabetes: results from an ancillary Look AHEAD study, Diabetes Care, 36, 2937, 10.2337/dc13-0315 · DOI · Paper page
  139. Sarwer, 2014, Changes in sexual functioning and sex hormone levels in women following bariatric surgery, JAMA Surg, 149, 26, 10.1001/jamasurg.2013.5022 · DOI
  140. Khan, 2013, Effect of depression and anxiety on the success of pelvic floor muscle training for pelvic floor dysfunction, J Obstet Gynaecol, 33, 710, 10.3109/01443615.2013.813913 · DOI · Paper page
  141. Buster, 2013, Managing female sexual dysfunction, Fertil Steril, 100, 905, 10.1016/j.fertnstert.2013.08.026 · DOI · Paper page
  142. Davis, 2012, Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women, J Sex Med, 9, 1134
  143. Tuiten, 2002, Can sublingual testosterone increase subjective and physiological measures of laboratory induced sexual arousal?, Arch Gen Psychiatry, 59, 465, 10.1001/archpsyc.59.5.465 · DOI
  144. Heard-Davison, 2007, Genital and subjective measurement of the time course effects of an acute dose of testosterone vs. placebo in postmenopausal women, J Sex Med, 4, 209
  145. Pessina, 2006, Differential effects of estradiol, progesterone, and testosterone on vaginal structural integrity, Endocrinology, 147, 61, 10.1210/en.2005-0870 · DOI
  146. Fernandes, 2014, Efficacy of vaginally applied estrogen, testosterone, or polyacrylic acid on sexual function in postmenopausal women: a randomized controlled trial, J Sex Med, 11, 1262
  147. Witherby, 2011, Topical testosterone for breast cancer patients with vaginal atrophy related to aromatase inhibitors: a phase I/II study, Oncologist, 16, 424, 10.1634/theoncologist.2010-0435 · DOI · Paper page
  148. Nappi, 2015, Advances in pharmacotherapy for treating female sexual dysfunction, Expert Opin Pharmacother, 16, 875, 10.1517/14656566.2015.1020791 · DOI
  149. Biglia, 2010, Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials, Gynecol Endocrinol, 26, 804, 10.3109/09513590.2010.495437 · DOI
  150. Davis, 2002, The effects of tibolone on mood and libido, Menopause, 9, 162, 10.1097/00042192-200205000-00004 · DOI
  151. Laan, 2001, The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women, Climacteric, 4, 28, 10.1080/cmt.4.1.28.41 · doi:10.1080/cmt.4.1.28.41 · Paper page
  152. Uygur, 2005, Effect on sexual life—a comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate, Gynecol Endocrinol, 20, 209, 10.1080/09513590400027240 · DOI
  153. Nijland, 2008, Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial, J Sex Med, 5, 646
  154. Laan, 2002, The enhancement of vaginal vasocongestion by sildenafil in healthy premenopausal women, J Womens Health Gender Based Med, 11, 357, 10.1089/152460902317585994 · DOI · Paper page
  155. Basson, 2002, Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder, J Womens Health Gender Based Med, 11, 367, 10.1089/152460902317586001 · DOI · Paper page
  156. Berman, 2003, Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study, J Urol, 170, 2333
  157. Caruso, 2003, The function of sildenafil on female sexual pathways: a double-blind, cross-over, placebo-controlled study, Eur J Obstet Gynecol Reprod Biol, 110, 201, 10.1016/S0301-2115(03)00118-0 · DOI
  158. Caruso, 2001, Premenopausal women affected by sexual arousal disorder treated with sildenafil: a double-blind, cross-over, placebo-controlled study, BJOG, 108, 623
  159. Caruso, 2006, Sildenafil improves sexual functioning in premenopausal women with type 1 diabetes who are affected by sexual arousal disorder: a double-blind, crossover, placebo-controlled pilot study, Fertil Steril, 85, 1496, 10.1016/j.fertnstert.2005.10.043 · DOI
  160. DasGupta, 2004, Efficacy of sildenafil in the treatment of female sexual dysfunction due to multiple sclerosis, J Urol, 171, 1189
  161. Nurnberg, 2008, Sildenafil treatment of women with antidepressant-associated sexual dysfunction: a randomized controlled trial, JAMA, 300, 395, 10.1001/jama.2008.694 · DOI
  162. Sipski, 2000, Sildenafil effects on sexual and cardiovascular responses in women with spinal cord injury, Urology, 55, 812, 10.1016/S0090-4295(00)00493-3 · DOI · Paper page
  163. Schoen, 2009, Sildenafil citrate for female sexual arousal disorder: a future possibility?, Nat Rev Urol, 6, 216, 10.1038/nrurol.2009.25 · DOI
  164. Major, 2004, Pfizer will not apply for a license for sildenafil for women, BMJ, 382, 542
  165. Meston, 2002, The effects of yohimbine plus L-arginine glutamate on sexual arousal in postmenopausal women with sexual arousal disorder, Arch Sex Behav, 31, 323, 10.1023/A:1016220225392 · DOI
  166. Ito, 2001, A double-blind placebo-controlled study of ArginMax, a nutritional supplement for enhancement of female sexual function, J Sex Marital Ther, 27, 541, 10.1080/713846828 · DOI
  167. Islam, 2001, Topical alprostadil in the treatment of female sexual arousal disorder: a pilot study, J Sex Marital Ther, 27, 531, 10.1080/713846804 · DOI
  168. Fourcroy, 2003, Female sexual dysfunction—potential for pharmacotherapy, Drugs, 63, 1445, 10.2165/00003495-200363140-00002 · DOI
  169. Kielbasa, 2006, Topical alprostadil trament of female sexual arousal disorder, Ann Pharmacother, 40, 1369, 10.1345/aph.1G472 · doi:10.1345/aph.1g472
  170. Goldstein, 2013, Phase 3 clinical trial results with Femprox (R) treatment in FSAD patients show correlation of arousal with both lubrication and orgasm but not with desire, J Sex Med, 10, 164
  171. Rosen, 1999, Oral phentolamine and female sexual arousal disorder: a pilot study, J Sex Marital Ther, 25, 137, 10.1080/00926239908403987 · DOI
  172. Rubio-Aurioles, 2002, Phentolamine mesylate in postmenopausal women with female sexual arousal disorder: a psychophysiological study, J Sex Marital Ther, 28, 205, 10.1080/00926230252851339 · DOI
  173. Beharry, 2003, Evidence for centrally initiated genital vasocongestive engorgement in the female rat: findings from a new model of female sexual arousal response, Int J Impot Res, 15, 122, 10.1038/sj.ijir.3900980 · doi:10.1038/sj.ijir.3900980
  174. Tarcan, 2000, Systemic administration of apomorphine improves the hemodynamic mechanism of clitoral and vaginal engorgement in the rabbit, Int J Impot Res, 12, 235, 10.1038/sj.ijir.3900552 · doi:10.1038/sj.ijir.3900552
  175. Bechara, 2004, A double-blind randomized placebo control study comparing the objective and subjective changes in female sexual response using sublingual apomorphine, J Sex Med, 1, 209
  176. Taylor, 2013, Strategies for managing sexual dysfunction induced by antidepressant medication, Cochrane Database Syst Rev, 5, CD003382
  177. Gitlin, 2002, Bupropion-sustained release as a treatment for SSRI-induced sexual side effects, J Sex Marital Ther, 28, 131, 10.1080/00926230252851870 · DOI · Paper page
  178. Ferguson, 2003, Randomized, placebo-controlled, double blind, crossover design trial of the efficacy and safety of Zestra for Women in women with and without female sexual arousal disorder, J Sex Marital Ther, 29, 33, 10.1080/713847125 · DOI
  179. Basson, 2003, Definitions of women's sexual dysfunction reconsidered: advocating expansion and revision, J Psychosom Obstet Gynaecol, 24, 221, 10.3109/01674820309074686 · DOI · Paper page
  180. Carey, 2006, Pharmacological effects on sexual function, Obstet Gynecol Clin North Am, 33, 599, 10.1016/j.ogc.2006.10.005 · DOI
  181. Barbach, 1974, Group treatment of preorgasmic women, J Sex Marital Ther, 1, 139, 10.1080/00926237408405281 · DOI
  182. McMullen, 1979, Self-administered masturbation training in the treatment of primary orgasmic dysfunction, J Consult Clin Psychol, 47, 912, 10.1037/0022-006X.47.5.912 · DOI
  183. Nairne, 1983, The use of directed masturbation training in the treatment of primary anorgasmia, Br J Clin Psychol, 22, 283, 10.1111/j.2044-8260.1983.tb00615.x · doi:10.1111/j.2044-8260.1983.tb00615.x
  184. Riley, 1978, A controlled study to evaluate directed masturbation in the management of primary orgasmic failure in women, Br J Psychiatry, 133, 404, 10.1192/bjp.133.5.404 · DOI
  185. Dodge, 1982, Bibliotherapy in the treatment of female orgasmic dysfunction, J Consult Clin Psychol, 50, 442, 10.1037/0022-006X.50.3.442 · DOI
  186. Kilmann, 1987, The treatment of secondary orgasmic dysfunction II, J Sex Marital Ther, 13, 93, 10.1080/00926238708403882 · DOI
  187. Milan, 1988, Treatment outcome of secondary orgasmic dysfunction: a two- to six-year follow-up, Arch Sex Behav, 17, 463, 10.1007/BF01542336 · DOI
  188. Eichel, 1988, The technique of coital alignment and its relation to female orgasmic response and simultaneous orgasm, J Sex Marital Ther, 14, 129, 10.1080/00926238808403913 · DOI
  189. Mah, 2002, Do all orgasms feel alike? Evaluating a two-dimensional model of the orgasm experience across gender and sexual context, J Sex Res, 39, 104
  190. King, 2011, Are there different types of female orgasm?, Arch Sex Behav, 40, 865, 10.1007/s10508-010-9639-7 · DOI
  191. Meston, 2004, Women's orgasm, Annu Rev Sex Res, 15, 173, 10.1080/10532528.2004.10559820 · DOI · Paper page
  192. Glenn, 1968, Types of orgasm in women. A critical review and redefinition, J Am Psychoanal Assoc, 16, 549, 10.1177/000306516801600309 · doi:10.1177/000306516801600309
  193. Brody, 2007, Vaginal orgasm is associated with better psychological function, Sex Relatsh Ther, 22, 173, 10.1080/14681990601059669 · DOI
  194. Meston, 2004, Disorders of orgasm in women, J Sex Med, 1, 66
  195. Wallen, 2011, Female sexual arousal: genital anatomy and orgasm in intercourse, Horm Behav, 59, 780, 10.1016/j.yhbeh.2010.12.004 · DOI
  196. Harris, 2008, Normal variations in personality are associated with coital orgasmic infrequency in heterosexual women: a population-based study, J Sex Med, 5, 1177
  197. Darling, 1986, Enhancing relationships: understanding the feminine mystique of pretending orgasm, J Sex Marital Ther, 12, 182, 10.1080/00926238608415405 · DOI
  198. Dawood, 2005, Genetic and environmental influences on the frequency of orgasm in women, Twin Res Hum Genet, 8, 27, 10.1375/twin.8.1.27 · doi:10.1375/twin.8.1.27
  199. Dunn, 2005, Genetic influences on variation in female orgasmic function: a twin study, Biol Lett, 1, 260, 10.1098/rsbl.2005.0308 · DOI · Paper page
  200. Garcia, 2014, Variation in orgasm occurrence by sexual orientation in a sample of U.S. singles, J Sex Med, 11, 2645

200 of 262 shown

Cited by

See all 125

Metadata

Authors
Kingsberg, S. A., Althof, S., Simon, J. A., Bradford, A., Bitzer, J., Carvalho, J., Flynn, K. E., Nappi, R. E., Reese, J. B., Rezaee, R. L., Schover, L., & Shifrin, J. L.
Venue
The Journal of Sexual Medicine
Published
2017-12-01
Volume
14
Issue
12
Pages
1463-1491
ISSN
  • 1743-6095 (ISSN-L)
  • 1743-6109
OpenAlex
W2771515094
Cited by
125
References
41
FWCI
7.97
Type
journal article
Language
en
Update notices
erratum (2018-02-01)
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.